Prot# NU C05N1: A Phase III Randomized Trial of Docetaxel Based Induction Chemotherapy in Patients with N2/N3 Locally Advanced Head and Neck Cancer

  • Agulnik, Mark (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date8/1/058/1/12

Funding

  • University of Chicago (NU C05N1)
  • Aventis Pharmaceuticals Inc. (NU C05N1)